NASDAQ:PHAR
Pharming Group N.V.
- Stock
Last Close
0.91
26/04 16:35
Market Cap
788.51M
Beta: 0.95
Volume Today
580
Avg: 26.41K
PE Ratio
−37.26
PFCF: −31.36
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|
average inventory | 18.70M - | 24.24M 29.62% | 34.80M 43.60% | 49.54M 42.35% | ||
average payables | 9.74M - | 27.96M 186.98% | 48.45M 73.27% | 35.24M 27.25% | ||
average receivables | 29.11M - | 30.94M 6.31% | 28.79M 6.98% | 35.12M 22.00% | ||
book value per share | 0.19 - | 0.29 54.23% | 0.30 3.96% | 0.31 4.70% | 0.33 5.95% | |
capex per share | -0.04 - | -0.03 36.28% | -0.02 3.97% | -0.00 87.78% | -0.00 26.61% | |
capex to depreciation | -4.39 - | -1.84 58.06% | -0.85 53.68% | -0.15 82.41% | -0.09 38.68% | |
capex to operating cash flow | -0.34 - | -0.18 46.96% | -0.44 144.01% | -0.09 80.45% | 0.08 198.00% | |
capex to revenue | -0.13 - | -0.07 46.34% | -0.08 16.56% | -0.01 88.56% | -0.01 37.93% | |
cash per share | 0.12 - | 0.32 174.81% | 0.30 7.53% | 0.32 6.63% | 0.32 2.01% | |
days of inventory on hand | 247.27 - | 305.26 23.45% | 493.38 61.63% | 879.68 78.30% | 821.73 6.59% | |
days payables outstanding | 91.46 - | 194.34 112.49% | 767.29 294.81% | 1.13K 47.53% | 231.95 79.51% | |
days sales outstanding | 50.66 - | 51.04 0.75% | 57.58 12.83% | 49.03 14.86% | 63.41 29.33% | |
debt to assets | 0.23 - | 0.39 70.19% | 0.41 5.19% | 0.39 3.84% | 0.37 5.33% | |
debt to equity | 0.50 - | 0.88 78.08% | 0.84 5.03% | 0.81 2.85% | 0.78 3.74% | |
dividend yield | ||||||
earnings yield | 0.04 - | 0.05 19.70% | 0.03 38.64% | 0.02 41.03% | -0.01 174.51% | |
enterprise value | 945.56M - | 761.88M 19.43% | 463.06M 39.22% | 708.17M 52.93% | 885.09M 24.98% | |
enterprise value over ebitda | 12.54 - | 8.27 34.03% | 9.95 20.25% | 21.72 118.38% | -311.87 1,535.94% | |
ev to operating cash flow | 12.68 - | 8.37 33.97% | 12.82 53.06% | 30.93 141.29% | -51.16 265.40% | |
ev to sales | 4.99 - | 3.34 33.21% | 2.44 26.88% | 3.44 41.20% | 3.61 4.76% | |
free cash flow per share | 0.08 - | 0.12 49.34% | 0.03 73.17% | 0.03 2.27% | -0.03 188.90% | |
free cash flow yield | 0.05 - | 0.09 81.21% | 0.04 55.81% | 0.03 31.68% | -0.02 186.64% | |
graham net net | -0.06 - | 0.01 112.37% | 0.04 404.64% | 0.04 17.02% | 0.05 4.87% | |
graham number | 0.52 - | 0.64 23.35% | 0.40 37.77% | 0.39 3.86% | 0.35 10.00% | |
income quality | 1.09 - | 1.92 75.40% | 1.64 14.45% | 1.53 6.83% | 1.44 5.72% | |
intangibles to total assets | 0.31 - | 0.22 27.54% | 0.21 6.15% | 0.18 16.39% | 0.15 12.73% | |
interest coverage | 5.11 - | 12.83 151.02% | 4.71 63.32% | 3.40 27.69% | -0.90 126.54% | |
interest debt per share | 0.11 - | 0.27 132.18% | 0.26 1.54% | 0.26 1.27% | 0.27 2.25% | |
inventory turnover | 1.48 - | 1.20 19.00% | 0.74 38.13% | 0.41 43.91% | 0.44 7.05% | |
invested capital | 0.50 - | 0.88 78.08% | 0.84 5.03% | 0.81 2.85% | 0.78 3.74% | |
market cap | 961.69M - | 805.15M 16.28% | 493.20M 38.74% | 748.81M 51.83% | 775.28M 3.53% | |
net current asset value | -19.07M - | 28.24M 248.06% | 45.00M 59.33% | 56.34M 25.21% | 72.27M 28.27% | |
net debt to ebitda | -0.21 - | -0.47 119.62% | -0.65 37.77% | -1.25 92.63% | -38.69 3,003.59% | |
net income per share | 0.06 - | 0.06 1.35% | 0.02 62.75% | 0.02 11.72% | -0.02 176.45% | |
operating cash flow per share | 0.12 - | 0.14 20.12% | 0.06 60.65% | 0.04 37.51% | -0.03 174.89% | |
payables turnover | 3.99 - | 1.88 52.94% | 0.48 74.67% | 0.32 32.22% | 1.57 388.02% | |
receivables turnover | 7.21 - | 7.15 0.74% | 6.34 11.37% | 7.44 17.45% | 5.76 22.68% | |
research and ddevelopement to revenue | 0.17 - | 0.18 8.17% | 0.35 94.91% | 0.26 27.80% | 0.28 9.96% | |
return on tangible assets | 0.23 - | 0.13 45.61% | 0.05 61.01% | 0.04 20.04% | -0.03 169.08% | |
revenue per share | 0.30 - | 0.36 18.74% | 0.30 17.62% | 0.32 6.79% | 0.37 18.24% | |
roe | 0.35 - | 0.22 36.04% | 0.08 64.17% | 0.07 15.68% | -0.05 172.15% | |
roic | 0.29 - | 0.20 31.95% | 0.05 73.93% | 0.04 20.07% | -0.01 127.17% | |
sales general and administrative to revenue | 0.11 - | 0.06 43.58% | 0.19 194.50% | 0.22 20.37% | 0.33 46.97% | |
shareholders equity per share | 0.19 - | 0.29 54.23% | 0.30 3.96% | 0.31 4.70% | 0.33 5.95% | |
stock based compensation to revenue | 0.03 - | 0.05 47.81% | 0.03 31.74% | 0.04 21.31% | ||
tangible asset value | 37.94M - | 89.49M 135.88% | 108.97M 21.76% | 129.52M 18.86% | 147.51M 13.90% | |
tangible book value per share | 0.06 - | 0.14 132.19% | 0.17 20.67% | 0.20 17.19% | 0.22 12.88% | |
working capital | 5.17M - | 186.66M 3,509.21% | 202.46M 8.47% | 217.80M 7.58% | 238.37M 9.45% |
All numbers in USD (except ratios and percentages)